{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:28Z","timestamp":1759334668774,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jfo.2016.10.017","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T22:31:18Z","timestamp":1490049078000},"page":"408-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacit\u00e9 pr\u00e9coce de l\u2019implant de dexam\u00e9thasone (OZURDEX\u00ae) \u00e9valu\u00e9e en vraie vie dans le traitement de l\u2019\u0153d\u00e8me maculaire diab\u00e9tique"],"prefix":"10.1016","volume":"40","author":[{"given":"V.","family":"Sarda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fajnkuchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nghiem-Buffet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Grenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Chaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Giocanti-Auregan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2016.10.017_bib0090","series-title":"Macular edema dev ophthalmol","first-page":"73","article-title":"Diabetic macular edema","author":"Bandello","year":"2010"},{"key":"10.1016\/j.jfo.2016.10.017_bib0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1742-1241.2006.01211.x","article-title":"Diabetic macular oedema: a clinical overview","volume":"61","author":"Girach","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jfo.2016.10.017_bib0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30\u00a0years","volume":"102","author":"Klein","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2016.10.017_bib0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of retinopathy when age at diagnosis is 30\u00a0or more years","volume":"102","author":"Klein","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2016.10.017_bib0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(95)31052-4","article-title":"The Wisconsin epidemiology study of diabetic retinopathy. XV. The longterm incidence of macular edema","volume":"102","author":"Klein","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.10.017_bib0115","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jfo.2015.08.003","article-title":"Diabetic macular edema: diagnosis and pre-treatment work-up. Physician information sheet: treatment of diabetic macular edema","volume":"38","author":"Massin","year":"2015","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2016.10.017_bib0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: ranibizumab mono-therapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.10.017_bib0125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2\u00a0phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.10.017_bib0130","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.10.017_bib0135","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/eye.2015.214","article-title":"A randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study)","volume":"29","author":"Ramu","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2016.10.017_bib0140","article-title":"A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study)","author":"Heng","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.10.017_bib0145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jfo.2014.03.001","article-title":"Multicenter Ozurdex\u00ae assessment for diabetic macular edema: MOZART study","volume":"37","author":"Guigou","year":"2014","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2016.10.017_bib0150","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jfo.2014.08.002","article-title":"Severity of diabetic macular edema (DME) in Seine St Denis among patients treated by anti-VEGF","volume":"37","author":"St\u00e9phan","year":"2014","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2016.10.017_bib0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000371770","article-title":"Dexamethasone implants in patients with na\u00efve or refractory diffuse diabetic macular edema","volume":"233","author":"Escobar-Barranco","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jfo.2016.10.017_bib0160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5301\/ejo.5000563","article-title":"Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment","volume":"25","author":"Panozzo","year":"2015","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.10.017_bib0165","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.ophtha.2014.07.002","article-title":"A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study","volume":"121","author":"Gillies","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.10.017_bib0085","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/IAE.0000000000000490","article-title":"Intravitreal dexamethasone implant in patients with ranibizumab persistent diabetic macular edema","volume":"35","author":"Zhioua","year":"2015","journal-title":"Retina"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217300815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217300815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:07:07Z","timestamp":1759259227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551217300815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0181551217300815"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2016.10.017","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacit\u00e9 pr\u00e9coce de l\u2019implant de dexam\u00e9thasone (OZURDEX\u00ae) \u00e9valu\u00e9e en vraie vie dans le traitement de l\u2019\u0153d\u00e8me maculaire diab\u00e9tique","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2016.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}